Return on Assets: An indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Calculated as: Income from Continuing Operations / Total Assets
CNS Pharmaceuticals, Inc. (CNSP) had Return on Assets of -69.07% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-5.96M |
|
-- |
|
-- |
|
$5.99M |
|
$-5.99M |
|
$0.03M |
|
$-5.96M |
|
$-5.96M |
|
$-5.96M |
|
$-5.96M |
|
$-5.96M |
|
$-5.96M |
|
$-5.99M |
|
$-5.99M |
|
0.44M |
|
0.44M |
|
$-4.60 |
|
$-4.60 |
|
| Balance Sheet Financials | |
$8.10M |
|
$0.02M |
|
$0.52M |
|
$8.62M |
|
$4.10M |
|
-- |
|
-- |
|
$4.10M |
|
$4.52M |
|
$4.52M |
|
$4.52M |
|
0.63M |
|
| Cash Flow Statement Financials | |
$-13.81M |
|
$-0.02M |
|
$14.57M |
|
$6.46M |
|
$7.20M |
|
$0.74M |
|
$0.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.98 |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.83M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-131.69% |
|
-131.69% |
|
|
Return on Assets |
-69.07% |
-131.69% |
|
$7.14 |
|
$-31.22 |
|
$-31.18 |
|